Taking people in SloveniaNo phase
Myval Global Study of Myval™ THV Series Implanted in Patients With Native Severe Aortic Valve Stenosis.
Key facts
- Who runs it
- Meril Life Sciences Pvt. Ltd.
- Where
- Ljubljana, SloveniaSee the siteAlso in 6 other countries, 7 sites
- Trial code
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 7 Aug 2020
- Expected to end
- 30 Nov 2028
- Type of study
- Observational
- Treatments tested
- Myval Transcatheter Heart Valve Series
- Record updated
- 4 March 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- All patients of this study must have received Myval™ THV series for treatment of native severe aortic stenosis and completed a minimum of 30-day follow-up
Who cannot take part
- No
Where in Slovenia
Also in 6 other countries, 7 sites
- University Medical Centre LjubljanaLjubljana, SloveniaContact: Prof. Matjaz BuncTaking people
About the trial
What the trial wants to find out
A retrospective, multinational, multicentre, observational study in patients presenting with native severe aortic valve stenosis and treated with Myval™ Transcatheter Heart Valve Series in real-world setting.
Treatments tested
- Myval Transcatheter Heart Valve Series
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Retrospective, Multinational, Multicentre, Observational Study in Patients Presenting With Native Severe Aortic Valve Stenosis and Treated With Myval™ Transcatheter Heart Valve Series in Real-world Setting.
- Record updated
- 4 March 2024